GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiRx Inc (ROCO:6580) » Definitions » Capex-to-Revenue

TaiRx (ROCO:6580) Capex-to-Revenue : 0.00 (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is TaiRx Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

TaiRx's Capital Expenditure for the six months ended in Jun. 2024 was NT$0.00 Mil. Its Revenue for the six months ended in Jun. 2024 was NT$0.27 Mil.

Hence, TaiRx's Capex-to-Revenue for the six months ended in Jun. 2024 was 0.00.


TaiRx Capex-to-Revenue Historical Data

The historical data trend for TaiRx's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiRx Capex-to-Revenue Chart

TaiRx Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.10 0.12 0.18 0.05 0.06

TaiRx Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of TaiRx's Capex-to-Revenue

For the Biotechnology subindustry, TaiRx's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TaiRx's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TaiRx's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where TaiRx's Capex-to-Revenue falls into.



TaiRx Capex-to-Revenue Calculation

TaiRx's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.313) / 5.082
=0.06

TaiRx's Capex-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0.265
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TaiRx  (ROCO:6580) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


TaiRx Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of TaiRx's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


TaiRx Business Description

Traded in Other Exchanges
N/A
Address
No. 66, Sanchong Road, 1st Floor, 6th Floor, Nangang District, Taipei, TWN, 11502
TaiRx Inc is a pharmaceutical company based in Taiwan. It develops new drug and also makes improvements on current standard treatments in order to promptly find cures for major diseases and fulfill unmet medical needs. The company focuses on the new drug development for Asian and global markets.

TaiRx Headlines

No Headlines